These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 22472509

  • 1. Novel agents for the management of castration-resistant prostate cancer.
    Haddad H, Garcia JA.
    Curr Opin Urol; 2012 May; 22(3):175-82. PubMed ID: 22472509
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Castration-resistant prostate cancer: many treatments, many options, many challenges ahead.
    Garcia JA, Rini BI.
    Cancer; 2012 May 15; 118(10):2583-93. PubMed ID: 22038761
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New therapies for castration-resistant prostate cancer: efficacy and safety.
    Beltran H, Beer TM, Carducci MA, de Bono J, Gleave M, Hussain M, Kelly WK, Saad F, Sternberg C, Tagawa ST, Tannock IF.
    Eur Urol; 2011 Aug 15; 60(2):279-90. PubMed ID: 21592649
    [Abstract] [Full Text] [Related]

  • 8. Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer.
    Rove KO, Crawford ED.
    Curr Opin Urol; 2013 May 15; 23(3):208-13. PubMed ID: 23492838
    [Abstract] [Full Text] [Related]

  • 9. Novel chemotherapies in development for management of castration-resistant prostate cancer.
    Tewari AK, George DJ.
    Curr Opin Urol; 2013 May 15; 23(3):220-9. PubMed ID: 23511791
    [Abstract] [Full Text] [Related]

  • 10. Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC).
    Tsao CK, Galsky MD, Small AC, Yee T, Oh WK.
    BJU Int; 2012 Dec 15; 110(11):1580-8. PubMed ID: 22985411
    [Abstract] [Full Text] [Related]

  • 11. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, Heidenreich A.
    Actas Urol Esp; 2011 Dec 15; 35(10):565-79. PubMed ID: 21757258
    [Abstract] [Full Text] [Related]

  • 12. Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
    Lee DJ, Cha EK, Dubin JM, Beltran H, Chromecki TF, Fajkovic H, Scherr DS, Tagawa ST, Shariat SF.
    BJU Int; 2012 Apr 15; 109(7):968-85. PubMed ID: 22035221
    [Abstract] [Full Text] [Related]

  • 13. Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer.
    MacVicar GR, Hussain MH.
    Curr Opin Oncol; 2013 May 15; 25(3):252-60. PubMed ID: 23511665
    [Abstract] [Full Text] [Related]

  • 14. Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor.
    Bryce A, Ryan CJ.
    Clin Pharmacol Ther; 2012 Jan 15; 91(1):101-8. PubMed ID: 22130117
    [Abstract] [Full Text] [Related]

  • 15. Targeting continued androgen receptor signaling in prostate cancer.
    Massard C, Fizazi K.
    Clin Cancer Res; 2011 Jun 15; 17(12):3876-83. PubMed ID: 21680543
    [Abstract] [Full Text] [Related]

  • 16. Management of patients with castration-resistant disease.
    Pezaro C, Omlin A, Lorente D, de Bono J.
    Hematol Oncol Clin North Am; 2013 Dec 15; 27(6):1243-60, ix. PubMed ID: 24188261
    [Abstract] [Full Text] [Related]

  • 17. Current and emerging treatments in the management of castration-resistant prostate cancer.
    Shapiro D, Tareen B.
    Expert Rev Anticancer Ther; 2012 Jul 15; 12(7):951-64. PubMed ID: 22845410
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Update on castrate-resistant prostate cancer: 2010.
    Lassi K, Dawson NA.
    Curr Opin Oncol; 2010 May 15; 22(3):263-7. PubMed ID: 20177381
    [Abstract] [Full Text] [Related]

  • 20. Castration-resistant prostate cancer: AUA Guideline.
    Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M, Lin DW, Lowrance WT, Murad MH, Oh WK, Penson DF, Kibel AS.
    J Urol; 2013 Aug 15; 190(2):429-38. PubMed ID: 23665272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.